Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Alieva, Maria ^a   Bagó, Juli R ^a   Aguilar, Elisabet ^a   Soler Botija, Carolina ^b   Vila, Olaia F ^a   Molet, Joan ^c   Gambhir, Sanjiv S ^d   Rubio, Nuria ^a   Blanco, Jerónimo ^a  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; LUCIFERASE; RED FLUORESCENT PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER THERAPY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CELL THERAPY; CONTROLLED STUDY; DNA MODIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; TISSUE SPECIFICITY; TREATMENT RESPONSE; TUMOR CELL;

ANIMALS; BYSTANDER EFFECT; CELL DIFFERENTIATION; CELL LINE, TUMOR; GANCICLOVIR; GENE EXPRESSION; GLIOBLASTOMA; GRAFT SURVIVAL; HUMANS; LUMINESCENT PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; MOLECULAR IMAGING; SENSITIVITY AND SPECIFICITY; THYMIDINE KINASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; PHOTINUS PYRALIS; RENILLA RENIFORMIS;

EID: 84859819546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035148     Document Type: Article

References (34)

1. Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R, (2010) Gliomas in adults. Dtsch Arztebl Int 107: 799-807; quiz 808.
2. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, et al. (2007) Central nervous system tumors. Mayo Clin Proc 82: 1271-1286.
3. Argyriou AA, Kalofonos HP, (2009) Molecularly targeted therapies for malignant gliomas. Mol Med 15: 115-122.
4. Aboody KS, Najbauer J, Danks MK, (2008) Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 15: 739-752.
5. Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, et al. (2010) Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One 5: e11813.
6. Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, et al. (2006) Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Strahlenther Onkol 182: 400-407.
7. Menon LG, Kelly K, Yang HW, Kim SK, Black PM, et al. (2009) Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 27: 2320-2330.
8. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, et al. (2002) The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 62: 5657-5663.
9. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, et al. (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6: 447-450.
10. Prockop DJ, (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
12. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
13. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C, (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67: 6304-6313.
14. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318.
15. Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, et al. (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96: 149-156.
16. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, et al. (2007) Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 86: 8-16.
17. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, et al. (2005) Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5: 1571-1584.
18. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, et al. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844.
19. Vilalta M, Degano IR, Bago J, Gould D, Santos M, et al. (2008) Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 17: 993-1003.
20. Altanerova V, Cihova M, Babic M, Rychly B, Ondicova K, et al. (2011) Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer.
21. Altaner C, (2008) Prodrug cancer gene therapy. Cancer Lett 270: 191-201.
22. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, et al. (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 90: 7024-7028.
23. Sangro B, Mazzolini G, Ruiz M, Ruiz J, Quiroga J, et al. (2010) A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther 17: 837-843.
24. Huang Q, Pu P, Xia Z, You Y, (2007) Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. J Neurooncol 82: 239-248.
25. Moolten FL, (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46: 5276-5281.
26. Vilalta M, Degano IR, Bago J, Aguilar E, Gambhir SS, et al. (2009) Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging. Gene Ther 16: 547-557.
27. Ray P, De A, Min JJ, Tsien RY, Gambhir SS, (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64: 1323-1330.
28. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, et al. (2009) Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 87: 642-652.
29. Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, et al. (2009) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190.
30. Bexell D, Scheding S, Bengzon J, (2010) Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther 18: 1067-1075.
31. Nakanishi C, Nagaya N, Ohnishi S, Yamahara K, Takabatake S, et al. (2011) Gene and Protein Expression Analysis of Mesenchymal Stem Cells Derived From Rat Adipose Tissue and Bone Marrow. Circ J.
32. Sanz L, Santos-Valle P, Alonso-Camino V, Salas C, Serrano A, et al. (2008) Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 75: 308-314.
33. Carroll NM, Chase M, Chiocca EA, Tanabe KK, (1997) The effect of ganciclovir on herpes simplex virus-mediated oncolysis. J Surg Res 69: 413-417.
34. Marconi P, Tamura M, Moriuchi S, Krisky DM, Niranjan A, et al. (2000) Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Mol Ther 1: 71-81.